GENERAL ATLANTIC, L.P. - ROYALTY PHARMA PLC ownership

Back to all holdings Add to watchlist

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
GENERAL ATLANTIC, L.P. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$40,710,000
-11.7%
1,500,0000.0%0.63%
-13.6%
Q2 2023$46,110,000
-14.7%
1,500,0000.0%0.73%
+15.8%
Q1 2023$54,045,000
-8.8%
1,500,0000.0%0.63%
-20.0%
Q4 2022$59,280,000
-1.6%
1,500,0000.0%0.78%
+10.6%
Q3 2022$60,270,000
-4.4%
1,500,0000.0%0.71%
-13.7%
Q2 2022$63,060,000
+7.9%
1,500,0000.0%0.82%
+54.1%
Q1 2022$58,440,000
-2.2%
1,500,0000.0%0.53%
+15.8%
Q4 2021$59,775,000
+10.3%
1,500,0000.0%0.46%
+45.4%
Q3 2021$54,210,000
-11.8%
1,500,0000.0%0.32%
-27.1%
Q2 2021$61,485,000
-6.0%
1,500,0000.0%0.44%
-43.2%
Q1 2021$65,430,000
-12.8%
1,500,0000.0%0.77%
-21.5%
Q4 2020$75,075,000
+19.0%
1,500,0000.0%0.98%
+0.2%
Q3 2020$63,105,000
-13.3%
1,500,0000.0%0.97%
-55.4%
Q2 2020$72,825,000–1,500,000–2.18%–
 Download
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders